logo Ibionextlogo Ibionext
  • HOME
  • ABOUT US
  • STRATEGY
  • TEAM
  • OUR COMPANIES
  • NEWS & MEDIA
  • CONTACT
  • Français
Twitter
LinkedIn

Year: 2016

Home 2016

Connaissez-vous iBionext ?

December 6, 2016NewsIbionext

PARIS, le 6 décembre 2016 – iBionext Growth Fund a été créé  en 2016 pour financer la croissance des nouvelles sociétés sélectionnées au sein du réseau de start-ups créé par Bernard Gilly en 2012.   L’objectif de cette initiative est…

iBionext Growth Fund renforce son équipe pour soutenir ses objectifs de croissance

December 6, 2016Press releasesIbionext

Stéphane Losik prend la responsabilité du Middle Office Paris, le 06 décembre 2016 – iBionext Growth Fund – nouveau fonds de capital-risque lancé début 2016, spécialisé dans la construction, le développement et l’accompagnement d’entreprises innovantes en santé, annonce aujourd’hui la…

iBionext selects RBC Investor & Treasury Services to provide custody services for its new innovation fund

November 16, 2016NewsIbionext

Paris, November 16, 2016 – RBC Investor & Treasury Services, part of the Royal Bank of Canada (RY on TSX and NYSE), today announced that it has been selected by iBionext to provide custody services, holding liabilities and positions for…

De belles biotechs en neurosciences

November 14, 2016NewsIbionext

14.11.16 – Biotechinfo – De belles biotechs en neurosciences  

Meet one of the Most Impressive French Biotech Entrepreneurs

November 14, 2016NewsIbionext

The previous executive profiles we did, namely on Joern Aldag and Philippe Dro, are hard acts to follow, but Bernard Gilly was more than up to it. Bernard has a broad set of achievements for a broad set of lessons…

Une “initiative” sera lancée pour promouvoir les biotechs dans la French Tech (Bpifrance)

November 2, 2016NewsIbionext

PARIS, 2 novembre 2016 (APM) – Le directeur général du groupe Bpifrance, Nicolas Dufourcq, a fait savoir lors d’une conférence de presse mercredi qu’une “initiative” serait lancée dans les mois à venir afin de créer une “identité” pour les biotechs…

Le Figaro TV: Bernard Gilly (iBionext) explique comment des implants permettent de retrouver la vue

October 27, 2016NewsIbionext

http://video.lefigaro.fr/figaro/video/bernard-gilly-ibionext-explique-comment-des-implants-permettent-de-retrouver-la-vue/5186987857001/

Une Start-up développant une caméra biomimétique lève 13.8M€

October 25, 2016NewsIbionext

http://www.lepoint.fr/automobile/actualites/une-start-up-developpant-une-camera-biomimetique-leve-13-8-m-eur-25-10-2016-2078372_683.php

iBionext Growth Fund initiates its first investment in Chronocam in a 15M$ Series B Round

October 24, 2016Press releasesIbionext

Intel Capital, 360 Capital Parners, CEA Investissement, Renault-Nissan, and Robert Bosch Venture Capital also participated. Paris, October 24th 2016 – iBionext Growth Fund, a new venture capital fund launched in early 2016, which builds, accompanies and leads the financing of…

iBionext Growth Fund plus que 54 M€ à trouver

September 20, 2016NewsIbionext

http://www.eei-biotechfinances.com/ibionext-growth-fund-plus-que-54-me-a-trouver/

Posts navigation

1 2 >

SEARCH

ARCHIVES

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016

CATEGORIES

  • Events (3)
  • News (78)
  • Press releases (67)

LATEST NEWS

  • Théa partners with Tilak Healthcare to promote OdySight: First remote monitoring solution for ophthalmology June 29, 2022
  • GrAI Matter Labs Unveils Life-Ready AI with GrAI VIP at GLOBAL INDUSTRIE May 16, 2022
  • Rigshospitalet, the main hospital in Denmark based in Copenhagen, collaborate with Chronolife for a clinical investigation in Oncology March 31, 2022
  • Europrotect partners with Chronolife for the development and production of a device to measure physiological data, integrated into a firefighter’s intervention suit to limit the risk of thermal stress March 13, 2022
  • OdySight, first remote monitoring solution in ophthalmology to be reimbursed by the Social Security March 9, 2022

CONTACT US

74, rue du Faubourg Saint-Antoine 75012 Paris
+33 1 76 21 47 50
contact@ibionext.com

LEGAL NOTICES

  • Cookies Policy
  • Privacy Policy
  • Terms of use
© 2023 iBionext. All rights reserved